Point-of-care (POC) diagnostics are used across care settings, from consumers’ homes to bedsides in hospital intensive care units. The point-of-care diagnostic industry marks the shift from curative to predictive medicine, and globally millions of dollars are spent annually on the market. Point-of-care diagnostics represent the middle ground between rapid testing performed near a patient that is low in complexity, and the advanced technology that uses clinical molecular diagnostics. To this end, point-of-care diagnostics seek rapid results with an ease-of-use operation. This collection of reports provides insight into the point-of-care diagnostics market’s developments, like its targeting of infectious diseases as initial objectives. Kalorama Information has routinely profiled the clinical POC diagnostics market in its product development trends, market opportunities, and current and future sales in several product categories. Our reports are leading resources for industry professionals interested in molecular POC diagnostics, retail clinic diagnostics, and physician office laboratory (POL) markets worldwide.
- Display 45 Products per page
Published: November 1, 2006 | Price: $1,500.00 – $5,990.00
This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...Published: November 1, 2008 | Price: $1,990.00 – $2,000.00
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012. With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management...Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: November 1, 2009 | Price: $3,995.00 – $7,990.00
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot...Published: December 1, 2010 | Price: $2,800.00 – $5,990.00
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Moreover POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. As more diagnostic...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...Published: July 27, 2012 | Price: $2,995.00 – $7,990.00
In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world, in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, is a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. Market numbers for business planning matched with a discovery of the trends that are impacting the industry. A realistic forecast five years into the future...Published: August 15, 2012 | Price: $995.00 – $1,995.00
Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever. Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require...Published: December 6, 2012 | Price: $1,995.00 – $8,400.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the...Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...Published: November 22, 2013 | Price: $1,995.00 – $4,000.00
The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by Kalorama Analyst Emil Salazar, defines the market worldwide for analyzers, point of care tests, stains and slides and imaging systems used in hematology testing. Hematology...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: February 5, 2014 | Price: $2,995.00 – $5,990.00
The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products. A good number of companies are producing or...Published: March 18, 2014 | Price: $1,995.00 – $3,990.00
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments...Published: April 16, 2014 | Price: $600.00 – $1,200.00
Results of the 2014 (Jan-Feb 2014) survey of glucose meter users.Published: August 13, 2014 | Price: $1,995.00 – $3,990.00
The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can...Published: August 15, 2014 | Price: $3,995.00 – $7,990.00
Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...Published: January 14, 2015 | Price: $1,995.00 – $3,995.00
This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD tests. The report provides global 2014 sales of equipment, reagents and other products related to in vitro diagnostic tests. Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include: Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other) Molecular (Infectious Disease [inc. molecular tests for...Published: June 2, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Clinical diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) diagnostic tests. The increasing introduction of transportable, portable, and handheld diagnostic instruments has resulted in the migration of point of care diagnostic testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: November 1, 2015 | Price: $3,500.00 – $7,000.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends...Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: December 29, 2015 | Price: $696.50 – $1,393.00
Point of Care (POC) Pregnancy and Fertility Testing Market The female reproductive system is complex both in structure and in function. From birth to senescence, the organs of the female reproductive system function in concert with each other, with the brain, and with other endocrine organs. This integrated functioning constitutes some of the most intricate and elegant processes of the human body. Because the functioning of the female reproductive system has an enormous impact on the life of the individual...Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...Published: January 22, 2016 | Price: $3,600.00 – $6,320.00
This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three in vitro diagnostic areas represent nearly one-half of the IVD market and the best growth opportunities. The Bundle features the exact published content in each of the three major Kalorama...Published: January 26, 2016 | Price: $796.00 – $1,592.00
Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...Published: February 26, 2016 | Price: $3,360.00 – $6,720.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth current sales and market opportunity and providing the following market information: Molecular POC Market for...Published: July 28, 2016 | Price: $6,000.00 – $12,000.00
This combined report offering allows customers of Kalorama research to have two titles, combining Kalorama's authoritative volume covering the entire world POC market with its more focused report on molecular POC systems. The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in medical practice. This report takes an in-depth look at the POC diagnostic testing market, both professional and self-testing. The report provides data on the size...Published: August 22, 2016 | Price: $3,600.00 – $7,200.00
This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 10th edition of this comprehensive look at the IVD industry. At 1,600 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2021 for defined segments of the IVD...Published: October 4, 2016 | Price: $2,396.00 – $4,792.00
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...Published: February 3, 2017 | Price: $3,196.00 – $6,392.00
The World Market for Point of Care (POC) Diagnostics World Market for Point of Care (POC) Diagnostics examines the worldwide market for POC, including the following information: Worldwide POC Test Market for every significant segment of POC Testing from 2014-2021; Worldwide POC Market Share of top manufacturers, 2016; Professional and Self-testing, 2016; Worldwide POC professional testing analysis by product subcategory, 2016; POC testing revenues in US, Europe, Japan, and the rest of the world, 2016; POC market revenues for Germany,...Published: May 4, 2017 | Price: $2,800.00 – $5,600.00
The POC market is considered evolving with growthopportunity.  Developing and developedmarkets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the future of POC testing, and also provides market sizing and forecast for: • The Global Point-of-Care Market, 2016-2021 • The Global POC Market by Testing...Published: July 19, 2017 | Price: $3,360.00 – $6,720.00
Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total) Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies,...Published: July 25, 2017 | Price: $2,800.00 – $5,600.00
Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the major market sub-segments for 2016-2021: In Vitro Diagnostic Sales by Market Segment (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose,...Published: August 15, 2017 | Price: $200.00 – $400.00
Coverage of major IVD industry events and trends July 2017.Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: October 5, 2017 | Price: $2,000.00 – $4,000.00
IVD Market Top 25 Companies: Revenue Performance, Products, Competitive Activity IVD Market Top 25 Companies presents advancements in in vitro diagnostics (IVD) by the Top 25 firms in the industry and provides an overview of the most recent trends and developments. Companies included are: Alere Inc. Arkray Beckman Coulter / Danaher Becton Dickinson Bio-Rad Laboratories bioMérieux Cepheid / Danaher Danaher Corp. (including Radiometer A/S) Grifols Hologic Illumina Instrumentation Laboratory / Werfen LabCorp, Laboratory Corporation of America Luminex Ortho Clinical Diagnostics...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: October 16, 2017 | Price: $3,600.00 – $7,200.00
Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose Market, Electrolytes Market, Cardiac Biomarkers Market, Enzymes Market, Proteins Market, Drugs of Abuse Market, Therapeutic Drugs Market, HbA1c Market, Other Commonly Tested Analytes] by Region) This Kalorama Information report, Clinical Chemistry Markets, examines the global market for clinical chemistry products and procedures. Among the products covered are instruments, reagents, and supporting consumables used worldwide in core laboratory and point-of-care (POC) medical testing. Clinical chemistry instruments consist of large multifunctional workstations...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...